| IPAD-DB ID | 
                        E00225 | 
                    
                    
                        | Name | 
                        N-butanol extract of Hedyotis diffusa | 
                    
                    
                        | Category | 
                        Natural extracts | 
                    
                    
                        | EC50 | 
                         | 
                    
                    
                        | IC50 | 
                         | 
                    
                    
                        | Inhibition | 
                        The number of Aβ deposits was significantly reduced by 47.5 % in CL2006 worms treated with 1.0 mg/mL HDB; | 
                    
                    
                        | Toxicity | 
                         | 
                    
                    
                        | ROS(reactive oxygen species) | 
                        Feeding HDB (1.0 mg/mL) reduced the ROS level by 50.8 % (p< .001) in CL4176 compared to control nematodes | 
                    
                    
                        | Metal Chelating | 
                        Al | 
                    
                    
                        | BBB(blood-brain barrier) | 
                         | 
                    
                    
                        | Target Protein | 
                        Aβ | 
                    
                    
                        | Effects | 
                        (1) HDB improved lifespan, locomotion, and stress resistance; (2) HDB decreased paralysis, the accumulation of ROS, and AChE activity; (3) HDB suppressed neuronal Aβ-expression-induced defects in chemotaxis behavior and increased SOD activity; (4) HDB also downregulated the Aβ mRNA level and decreased the number of Aβ deposits; (5) HDB increased the expression levels of sod-3, daf-16, hsf-1, and hsp-16.2 gene and upregulated hsp-16.2::GFP and gst-4::GFP expression; (6) HDB may protect against Aβ-induced toxicity in C. elegans via the insulin/insulin-like growth factor-1 (IGF-1) signaling pathway; (7) HDB-treated group were 38.3 % lower than those in the control group (p< 0.01); | 
                    
                    
                        | Research Models | 
                        Caenorhabditis elegans CL4176, CL2006, and CL2355 strains | 
                    
                    
                        | Main Source | 
                         | 
                    
                    
                        | Ref. Link | 
                         |